Benjamin F. Edwards & Company, Inc. Inogen Inc Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Inogen Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 142 shares of INGN stock, worth $1,696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142
Previous 38
273.68%
Holding current value
$1,696
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INGN
# of Institutions
143Shares Held
20.8MCall Options Held
119KPut Options Held
149K-
Camber Capital Management LP Boston, MA2MShares$23.9 Million0.62% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$19.5 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.56MShares$18.6 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$17.9 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.06MShares$12.6 Million1.38% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $273M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...